Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKYANASDAQ:AXDXNASDAQ:OMICNYSE:OWLT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKYAAkoya Biosciences$1.24-6.8%$1.21$0.93▼$3.42$61.94M1.35398,948 shs4.21 million shsAXDXAccelerate Diagnostics$0.65$0.03▼$2.09$857K0.22524,054 shs53.64 million shsOMICSingular Genomics Systems$20.01$20.01$5.34▼$23.41$50.83M1.8349,891 shsN/AOWLTOwlet$7.92+2.5%$5.41$2.75▼$8.11$130.84M1.6142,723 shs150,532 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKYAAkoya Biosciences0.00%-1.59%+0.40%-10.79%-47.01%AXDXAccelerate Diagnostics0.00%0.00%0.00%-94.22%-96.54%OMICSingular Genomics Systems0.00%0.00%0.00%0.00%+136.80%OWLTOwlet0.00%+11.63%+46.53%+115.80%+92.23%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKYAAkoya Biosciences2.1704 of 5 stars3.03.00.00.02.11.70.6AXDXAccelerate DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/AOMICSingular Genomics Systems0.3594 of 5 stars1.00.00.00.00.03.30.6OWLTOwlet0.7276 of 5 stars1.70.00.00.00.64.20.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKYAAkoya Biosciences 2.00Hold$2.51102.10% UpsideAXDXAccelerate Diagnostics 4.00Strong BuyN/AN/AOMICSingular Genomics Systems 2.00Hold$6.50-67.52% DownsideOWLTOwlet 3.33Buy$7.75-2.15% DownsideCurrent Analyst Ratings BreakdownLatest AXDX, AKYA, OWLT, and OMIC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025AKYAAkoya BiosciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.80 ➝ $1.084/29/2025AKYAAkoya BiosciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$3.50 ➝ $1.804/23/2025OWLTOwletNorthland CapmkSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/23/2025OWLTOwletNorthland SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$7.004/14/2025AKYAAkoya BiosciencesPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$2.40 ➝ $1.65(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKYAAkoya Biosciences$81.67M0.76N/AN/A$0.15 per share8.27AXDXAccelerate Diagnostics$11.70M0.00N/AN/A($1.37) per share0.00OMICSingular Genomics Systems$2.91M17.47N/AN/A$73.25 per share0.27OWLTOwlet$78.10M1.68$0.32 per share24.94($1.86) per share-4.26Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKYAAkoya Biosciences-$55.37M-$0.97N/AN/AN/A-59.44%-487.85%-35.86%8/4/2025 (Estimated)AXDXAccelerate Diagnostics-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/AOMICSingular Genomics Systems-$94.82M-$35.11N/A∞N/A-3,237.89%-57.87%-37.90%8/12/2025 (Estimated)OWLTOwlet-$12.54M-$1.43N/A46.59N/A-15.28%-0.36%0.20%8/11/2025 (Estimated)Latest AXDX, AKYA, OWLT, and OMIC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025AKYAAkoya Biosciences-$0.29-$0.32-$0.03-$0.32$20.19 million$16.64 million5/8/2025Q1 2025OWLTOwlet-$0.05-$0.07-$0.02$0.11$18.14 million$21.10 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKYAAkoya BiosciencesN/AN/AN/AN/AN/AAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/AOMICSingular Genomics SystemsN/AN/AN/AN/AN/AOWLTOwletN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKYAAkoya Biosciences10.120.610.40AXDXAccelerate DiagnosticsN/A1.501.34OMICSingular Genomics Systems0.047.376.67OWLTOwletN/A1.190.90Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKYAAkoya Biosciences79.42%AXDXAccelerate Diagnostics17.14%OMICSingular Genomics Systems65.80%OWLTOwlet72.60%Insider OwnershipCompanyInsider OwnershipAKYAAkoya Biosciences7.30%AXDXAccelerate Diagnostics43.60%OMICSingular Genomics Systems22.20%OWLTOwlet67.07%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKYAAkoya Biosciences9049.95 million46.31 millionOptionableAXDXAccelerate Diagnostics22025.21 million14.13 millionOptionableOMICSingular Genomics Systems2202.54 million1.97 millionNo DataOWLTOwlet10616.52 million5.44 millionNo DataAXDX, AKYA, OWLT, and OMIC HeadlinesRecent News About These CompaniesOwlet Inc. (OWLT) Stock Price Today - WSJJune 28 at 3:44 AM | wsj.comOwlet Amends Credit Agreement to Boost FlexibilityJune 16, 2025 | tipranks.com236,603 Shares in Owlet, Inc. (NYSE:OWLT) Purchased by Harbor Capital Advisors Inc.June 14, 2025 | marketbeat.comKalkine : Controls Owlet Stock on NYSE Composite DetailedJune 13, 2025 | kalkinemedia.comKPrivate equity firms own 28% of Owlet, Inc. (NYSE:OWLT) shares but individual investors control 41% of the companyJune 12, 2025 | finance.yahoo.comOwlet (NYSE:OWLT) Shares Up 13.8% - Here's WhyJune 3, 2025 | marketbeat.comInsider Selling: Owlet, Inc. (NYSE:OWLT) President Sells 3,604 Shares of StockMay 22, 2025 | insidertrades.comOwlet Supports NICU Families with $75,000 Donation of Dream Sock Monitors to March of DimesMay 15, 2025 | businesswire.comEarnings call transcript: Owlet’s Q1 2025 sees strong revenue growth, stock risesMay 10, 2025 | uk.investing.comOwlet raises 2025 revenue guidance to $91M-$95M amid strong Q1 growthMay 9, 2025 | seekingalpha.comOwlet Announces First Quarter 2025 Financial ResultsMay 9, 2025 | 01net.it0Owlet, Inc. (OWLT) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comOwlet to Report First Quarter 2025 Financial Results on May 8, 2025April 24, 2025 | businesswire.comOwlet files to sell 750K shares of common stock for holdersMarch 11, 2025 | markets.businessinsider.comEarnings call transcript: Owlet Q4 2024 reports 37% revenue growthMarch 6, 2025 | uk.investing.comTD Cowen Reaffirms Their Buy Rating on Owlet (OWLT)March 6, 2025 | markets.businessinsider.comOwlet (OWLT) Receives a Buy from Lake StreetMarch 6, 2025 | markets.businessinsider.comOwlet, Inc. (NYSE:OWLT) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | msn.comOwlet, Inc. Reports Record Growth and ExpansionMarch 5, 2025 | tipranks.comOwlet reports Q4 adjusted EPS (7c) vs (12c) last yearMarch 5, 2025 | markets.businessinsider.comOwlet sees FY25 revenue $88M-$92M, two estimates $88.91MMarch 5, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAXDX, AKYA, OWLT, and OMIC Company DescriptionsAkoya Biosciences NASDAQ:AKYA$1.24 -0.09 (-6.77%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$1.64 +0.40 (+32.26%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.Accelerate Diagnostics NASDAQ:AXDX$0.04 +0.04 (+∞) As of 05/14/2025 This is a fair market value price provided by Polygon.io. Learn more.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.Singular Genomics Systems NASDAQ:OMIC$20.01 0.00 (0.00%) As of 02/21/2025Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.Owlet NYSE:OWLT$7.92 +0.19 (+2.46%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$7.92 +0.00 (+0.06%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
